ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
232 Final Results of a Phase II Study of the Combination of Oral Vinorelbine (NVBo), Capecitabine (X) and Trastuzumab (H) in HER2-positive Metastatic Breast Cancer (MBC)
European Journal of Cancer
◽
10.1016/s0959-8049(12)70300-3
◽
2012
◽
Vol 48
◽
pp. S110
Author(s):
L. Petruzelka
◽
V. Ganju
◽
P.F. Conte
◽
N. Tubiana-Mathieu
◽
F. Majois
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
◽
Oral Vinorelbine
Download Full-text
Related Documents
Cited By
References
Phase II study of the combination of oral vinorelbine (NVBo), capecitabine (X), and trastuzumab (H) in HER2-positive, metastatic breast cancer (MBC): Recent analysis of the results with a median follow-up of 44 months.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.1077
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 1077-1077
◽
Cited By ~ 4
Author(s):
L. B. Petruzelka
◽
V. Ganju
◽
D. Becquart
◽
P. F. Conte
◽
N. Tubiana-Mathieu
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Recent Analysis
◽
Her2 Positive
◽
Oral Vinorelbine
Download Full-text
First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase II study
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(08)70894-2
◽
2008
◽
Vol 6
(7)
◽
pp. 220-221
Author(s):
A. Chan
◽
V. Ganju
◽
D. Becquart
◽
P.F. Conte
◽
L. Petruzelka
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Combination Therapy
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Efficacy And Safety
◽
First Line
◽
Her2 Positive
◽
Oral Vinorelbine
Download Full-text
Multicenter international phase II study of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) triple combination in HER2-positive metastatic breast cancer (MBC): updated results with a longer follow-up.
10.1158/0008-5472.sabcs-3151
◽
2009
◽
Author(s):
A Chan
◽
V Ganju
◽
D Becquart
◽
P Conte
◽
L Petruzelka
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Triple Combination
◽
Her2 Positive
◽
Oral Vinorelbine
Download Full-text
Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer
European Journal of Cancer
◽
10.1016/s0959-8049(02)80299-4
◽
2002
◽
Vol 38
(11)
◽
pp. S95
Author(s):
J Baselga
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Preliminary Data
◽
Phase Ii Study
◽
Metastatic Breast
◽
Weekly Schedule
◽
Her2 Positive
Download Full-text
SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer
Annals of Oncology
◽
10.1093/annonc/mdx365.084
◽
2017
◽
Vol 28
◽
pp. v106-v107
◽
Cited By ~ 3
Author(s):
P. Villagrasa Gonzalez
◽
A. Prat
◽
M. Oliveira
◽
L. de la Pena
◽
X. Gonzalez
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
Download Full-text
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study
Breast Cancer Research and Treatment
◽
10.1007/s10549-017-4203-y
◽
2017
◽
Vol 163
(3)
◽
pp. 507-515
◽
Cited By ~ 3
Author(s):
Konstantinos Tryfonidis
◽
◽
S. Marreaud
◽
H. Khaled
◽
B. De Valk
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Extracellular Domain
◽
Cardiac Safety
◽
Her2 Positive
◽
Serial Serum
Download Full-text
Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
Annals of Oncology
◽
10.1093/annonc/mdx365.015
◽
2017
◽
Vol 28
◽
pp. v81
Author(s):
N.M. Iyengar
◽
L.M. Smyth
◽
D. Lake
◽
A. Gucalp
◽
J.C. Singh
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
Download Full-text
Abstract OT1-1-13: A phase II study with lead-in safety cohort of cabazitaxel plus lapatinib as therapy for patients with HER2-positive metastatic breast cancer (MBC) and intracranial metastases
10.1158/0008-5472.sabcs13-ot1-1-13
◽
2013
◽
Author(s):
DA Yardley
◽
JD Hainsworth
◽
E Hamilton
◽
LL Hart
◽
M Shastry
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
◽
Intracranial Metastases
Download Full-text
Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
Annals of Oncology
◽
10.1093/annonc/mdw365.49
◽
2016
◽
Vol 27
◽
pp. vi84
◽
Cited By ~ 1
Author(s):
N.M. Iyengar
◽
L. Smyth
◽
D. Lake
◽
A. Gucalp
◽
J. Singh
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
Her2 Positive
Download Full-text
2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(07)70892-3
◽
2007
◽
Vol 5
(4)
◽
pp. 223
Author(s):
N. Tubiana-Mathieu
◽
P. Bougnoux
◽
D. Becquart
◽
A. Chan
◽
F. Majois
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Metastatic Breast
◽
First Line
◽
Oral Vinorelbine
◽
Line Chemotherapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close